| dc.contributor.author | Arik, N | |
| dc.contributor.author | Basoglu, T | |
| dc.contributor.author | Sungur, C | |
| dc.contributor.author | Adam, B | |
| dc.contributor.author | Bedir, A | |
| dc.contributor.author | Kandemir, T | |
| dc.contributor.author | Bernay, I | |
| dc.date.accessioned | 2020-06-21T15:50:38Z | |
| dc.date.available | 2020-06-21T15:50:38Z | |
| dc.date.issued | 1999 | |
| dc.identifier.issn | 1660-8151 | |
| dc.identifier.issn | 2235-3186 | |
| dc.identifier.uri | https://doi.org/10.1159/000045373 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/22435 | |
| dc.description | WOS: 000080266000015 | en_US |
| dc.description | PubMed: 10224490 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Karger | en_US |
| dc.relation.isversionof | 10.1159/000045373 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Hyperphosphatemia: A serious limiting factor preventing the possible benefit from intravenous calcitriol therapy | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 82 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 77 | en_US |
| dc.identifier.endpage | 78 | en_US |
| dc.relation.journal | Nephron | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
